These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 23050467

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Detection of infectious laryngotracheitis virus antibodies by glycoprotein-specific ELISAs in chickens vaccinated with viral vector vaccines.
    Godoy A, Icard A, Martinez M, Mashchenko A, García M, El-Attrachea J.
    Avian Dis; 2013 Jun; 57(2 Suppl):432-6. PubMed ID: 23901757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glycoprotein D peptide-based diagnostic approach for the detection of avian infectious laryngotracheitis antibodies.
    Kumar V, Yadav K, Kumar R, Chaudhary N, Kumar S.
    Avian Pathol; 2019 Dec; 48(6):602-609. PubMed ID: 31199165
    [Abstract] [Full Text] [Related]

  • 9. Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus (ILTV) and protective immunity.
    Sabir AJ, Adams TE, O'Rourke D, Devlin JM, Noormohammadi AH.
    Vet Microbiol; 2019 Jan; 228():252-258. PubMed ID: 30593375
    [Abstract] [Full Text] [Related]

  • 10. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M, Kumar S, Khattar SK, Gebreluul GT, Paldurai A, Samal SK.
    Vaccine; 2014 Jun 12; 32(28):3555-63. PubMed ID: 24793943
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
    Devlin JM, Browning GF, Hartley CA, Gilkerson JR.
    Vaccine; 2007 May 04; 25(18):3561-6. PubMed ID: 17316926
    [Abstract] [Full Text] [Related]

  • 13. Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators In Vitro and In Vivo.
    Coppo MJC, Devlin JM, Legione AR, Vaz PK, Lee SW, Quinteros JA, Gilkerson JR, Ficorilli N, Reading PC, Noormohammadi AH, Hartley CA.
    J Virol; 2018 Jan 01; 92(1):. PubMed ID: 29070686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR, Coppo MJ, Lee SW, Noormohammadi AH, Hartley CA, Browning GF, Gilkerson JR, O'Rourke D, Devlin JM.
    Vaccine; 2012 Nov 26; 30(50):7193-8. PubMed ID: 23084851
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG, Kim SJ.
    Avian Dis; 2003 Nov 26; 47(2):261-71. PubMed ID: 12887186
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus.
    Devlin JM, Viejo-Borbolla A, Browning GF, Noormohammadi AH, Gilkerson JR, Alcami A, Hartley CA.
    Vaccine; 2010 Feb 03; 28(5):1325-32. PubMed ID: 19932672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.